Searched for
GLAXOSMITHKLINE PLC
Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...- Glaxosmithkline Pharma Q1 Results: Net profit rises 8% to Rs 116 crore"Our results reflect good momentum across general medicines and vaccines during the quarter. We have delivered strong underlying growth wit...
- GSK Pharma completes deal with Novartis HealthcareDrug firm GlaxoSmithKline Pharmaceuticals has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis...
- Novartis India gets FIPB nod to sell OTC biz to GSK CPLNovartis India today said it has received FIPB approval to sell its OTC division to GlaxoSmithKline Consumer Pvt Ltd (GSK CPL).
- GSK Pharma to transfer cancer drug portfolio to Novartis armGlaxoSmithKline Pharmaceuticals board approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquirin...
- Novartis Q3 net loss at Rs 1.18 croreThe company had posted a net profit of Rs 15.23 crore in the same period last fiscal, Novartis India said in a filing to the Bombay Stock E...
- Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-croreNovartis's board approved sale of its OTC division to GSK Consumer Pvt Ltd, a consumer healthcare JV between Novartis AG & GSK, for a consi...
- Novartis shares up nearly 2% at closeShares of Novartis India ended nearly 2% higher after fair trade regulator CCI approved a multi-billion dollar deal between GlaxoSmithKline...
- GlaxoSmithKline Consumer Healthcare Ltd India-Novartis deal won't affect business in IndiaGlaxoSmithKline Consumer Healthcare today said the global deal between GlaxoSmithKline Plc and Novartis won't affect its business in India.
- GSK raises India unit stake to 75% via open offerWe are very pleased with the outcome of this transaction, which further increases our exposure to a strategically important market," GSK Ch...
- GSK Pharma shares slump over 8% ahead of closure of open offerShares of GlaxoSmithKline Pharmaceuticals slumped over 8 per cent as the open offer made by its UK-based parent to acquire additional stake...
- GlaxoSmithKline Consumer expands Horlicks portfolioHorlicks Kesar Badaam is the fourth variant in the Horlicks portfolio; the other flavours available are Malt, Chocolate and Elaichi.
- GSK's open offer for buying stake in Indian arm from February 7-21GlaxoSmithKline Plc's Rs 6,389.02 crore open offer to pick up 24.33 per cent stake in its Indian arm GlaxoSmithKline Pharma will start from...
- Parent offer talk spurs GSK PharmaIt may be the season of open offers by MNCs. GlaxoSmithKline Consumer started it earlier this year, followed by Unilever and, the latest, M...
- GlaxoSmithKline Consumer Q1 net up 19% at Rs 156 crGlaxoSmithKline Consumer Healthcare Ltd today posted 19 per cent increase in profit after tax at Rs 156 crore for the first quarter ended M...
- GlaxoSmithKline expands oral healthcare portfolio in IndiaAccording to industry estimates, oral healthcare market in India is around Rs 8,000 crore, of which toothpaste segment accounts for around ...
- GlaxoSmithKline Plc's open offer for GSKCH to start on January 17The UK-based GlaxoSmithKline Plc's open offer to acquire 31.8 per cent stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare w...
- GSK Consumer hits record high on parent company's plan to raise its stakeGSK Consumer surged 20% to hit its record high in early trade after its parent plans to raise its stake in Indian arm to 75%.
- GlaxoSmithKline net up 18 pc at Rs 136.74 croreGlaxoSmithKline Pharmaceuticals said its net profit rose by 18.18 per cent to Rs 136.74 crore for the quarter ended December 31, 2011.
- GlaxoSmithKline trimming US sales force by 1,000British drugmaker GlaxoSmithKline PLC is restructuring its US operations, starting with reducing its US sales force by 1,000.
Load More
